Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for pharmaceutical drugs largely in infectious application.
The pharmaceutical drug delivery technology market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period.
Recent Developments in the Industry:
# In 2020, Johnson & Johnson, Inc collaborated with Biomedical Advanced Research and Development Authority (BARDA), to expedite development and strengthen access through production of coronavirus vaccine.
# In 2020, Johnson & Johnson, Inc collaborated with MeiraGTx Holdings Plc (US) to develop, manufacture and commercialize its clinical stage inherited retinal disease drug portfolio.
# In 2019, Novartis signed an agreement with Shionogi (Japan) to commercialize new treatment, Rizmoic (Naldemedine) for Opiod-induced constipation in key European countries of Germany, UK and Netherlands, with rights of first refusal for some other European markets.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
In 2019, the infectious diseases segment accounted for the largest share
Based on application, the Pharmaceutical Drug Delivery Techniques Market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.
In 2019, the infectious diseases segment accounted for the largest share of the pharmaceutical drug delivery market. The large share of this segment can be majorly attributed to the increasing prevalence of infectious diseases and increasing company initiatives to enhance R&D related to infectious diseases. Further, spread of COVID-19 has further propelled the market for this application.
Market Size Estimation:
The total market size for pharmaceutical drug delivery technology market was arrived at after data triangulation from two different approaches, as mentioned below:
Approach to calculate the revenue of different players in the pharmaceutical drug delivery technology market
# Revenues for individual companies operating in the Pharmaceutical Drug Delivery Techniques Market were gathered from public sources and databases.
# Share of each product type of leading players was gathered from secondary sources to the extent available. In certain cases, the share of pharmaceutical drug delivery technology business has been ascertained after a detailed analysis of various parameters, including the product portfolio, market positioning, and geographic reach & strength, among others.
# Individual shares or revenue estimates were validated through expert interviews.
# The impact of COVID-19 was assessed using the quarterly reports of the companies and applied to the global market for impact assessment.
Approach to derive the market size and estimate market growth
# As a part of the primary research process, an individual respondent’s insights on the market size and market growth were taken during the interview (regional and global, as applicable).
# All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
In 2019, North America accounted for the largest share of the Pharmaceutical Drug Delivery Techniques Market
Geographically, North America accounted for the largest share of 39.3% of the market in 2019, followed by Europe. The large share of the North American market is due to factors such as growth in biologics in the pharmaceuticals market; the rising prevalence of chronic diseases such as cancer, respiratory allergies, and diabetes; increasing patient compliance to innovative drug delivery technologies; and the presence of a large number of prominent players in this region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Major Leaders:
The pharmaceutical drug delivery market is highly fragmented in nature with several big and emerging players. Johnson & Johnson, Inc. (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Pfizer, Inc. (US), Sanofi (France), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), 3M (US), Antares Pharma, Inc. (US), and Becton, Dickinson and Company (BD) (US) are some of the leading players operating in the global pharmaceutical drug delivery.
Players in this market pursue the strategies of product approvals, partnerships, agreements, collaborations, expansions, and acquisitions to develop and expand their market presence. Product approvals has been the key growth strategy adopted by players to expand their share in the market.
Thursday, August 20, 2020
Pharmaceutical Drug Delivery Market - Emerging Tech Innovations | Global Revenue Growth Expectations
Wednesday, August 19, 2020
Air Quality Monitoring System Market to Grow at a Healthy Rate | Major Players | Emerging Trends
What This Study is All About:
The study involved four major activities in estimating the current market size for the Air Quality Monitoring Research Market. Exhaustive secondary research was done to collect information on the market and its different subsegments.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
The global air quality monitoring system market (AQMS) is expected to reach USD 6.0 billion by 2025 from USD 4.3 billion in 2019, at a CAGR of 5.6%.
The major factors driving the growth of the air quality monitoring system market include the supportive government regulations for effective air pollution monitoring and control, ongoing initiatives towards the development of environment-friendly industries, increasing public-private funding for effective air pollution monitoring, rising levels of air pollution, and increasing public awareness related to the environmental and healthcare implications of air pollution.
Download PDF Brochure@
The indoor air quality monitors segment accounted for the largest share of the market in 2019
Based on the product, the Air Quality Monitoring Research Market is segmented into indoor monitors (comprising fixed and portable monitors), outdoor monitors (comprising fixed, portable, dust, and particulate monitors as well as AQM stations), and wearable monitors. The indoor monitors segment dominated the AQMS market in 2019. The large share of this segment is attributed to the increasing adoption of smart home and green-building technologies and growing consumer preference for pollution-free indoor environments.
Recent Developments:
# In March 2019, Thermo Fisher Scientific (US) launched the TriPlus 500 Gas Chromatography Headspace Autosampler.
# In February 2018, TSI (US) acquired 3M’s (US) Personal Safety Division, which includes offerings focused on noise, environmental, and heat stress monitoring. TSI also acquired 3M’s Oconomowoc, Wisconsin facility.
# In November 2017, Emerson (US) collaborated with Fluenta (Norway) to provide ultrasonic flare gas measurement solutions for the oil & gas and chemical industries. This collaboration was aimed at improving energy efficiency and compliance with regulations to monitor and report flare gas emissions across the globe.
Government agencies and academic institutes held the largest share of the AQMS market in 2019
Based on end-user, the air quality monitoring system market is segmented into government agencies and academic institutes, commercial and residential users, petrochemical industry, power generation plants, pharmaceutical industry, smart city authority, and other end users. The government agencies and academic institutes segment accounted for the largest share in 2018. The large share of this segment can be attributed to the presence of stringent environmental regulations, rising government investments for effective AQM, and increased installation of AQM stations worldwide.
Key Questions Addressed by the Report:
# What are the growth opportunities related to the adoption of AQMS products across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of AQMS products. Will this scenario continue in the next five years?
# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
# What are the new trends and advancements in the market?
Request Sample Pages@
Global Leaders:
The major players operating in the Air Quality Monitoring Research Market include Thermo Fisher Scientific (US), Emerson Electric (US), General Electric (US), Siemens AG (Germany), Teledyne Technologies (US), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Spectris plc (UK), 3M Company (US), Honeywell International Inc (US), HORIBA, Ltd. (Japan), Merck KGaA (Germany), TSI Incorporated (US), Tisch Environmental (US), and Testo (Germany), among others.
Analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the air quality monitoring systems market. Among these business strategies, product launches, agreements, and partnerships were the most widely adopted growth strategies by the players in the air quality monitoring systems market.
Monday, August 17, 2020
Nerve Monitoring System Market - Major Factors Boosting the Global Revenue
Target Audience for This Study:
# Nerve monitoring product manufacturers
# Nerve monitoring product suppliers and distributors
# Contract manufacturers
# Healthcare service providers [including hospitals, surgical centers, and ambulatory surgical centers (ASCs)]
# Research laboratories and academic institutes
# Clinical research organizations (CROs)
# Government regulatory authorities
# Independent associations and non-government organizations
# National and international regulatory authorities
# Market research firms
The Global Nerve Monitoring Devices Market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period.
Factors such as increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are expected to drive the demand for nerve monitoring products during the study period.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155669000
Based on the technology, the electromyography segment is expected to register highest growth rate during the forecast period
Based on technology, the nerve monitoring system market is divided into electroencephalography, electromyography, electrocorticography and evoked potential. Among these segments, electromyography is expected to grow at the highest CAGR during the forecast period. Growing availability of reimbursements for EMG-assisted surgical procedures in developed countries, significant use of EMG nerve monitoring for intraoperative applications, and technological advancements in the field are expected to drive the growth of the electromyography segment in the next five years.
Key Questions Addressed in this Study:
# What are the business growth strategies adopted by key market players to maintain their market position across key geographies?
# What is the existing developmental pipeline of major nerve monitoring systems among Medtech manufacturers as well as academia?
# Growing number of trauma based surgical procedures is a key trend in clinical management. What impact trauma based surgical procedures will have on nerve monitoring systems market during the forecast period?
# What alternative technologies/therapies are currently being used for nerve monitoring worldwide? What competition they pose for key nerve monitoring systems market players?
Based on application, neurosurgery is estimated to be the largest segment of the market in 2017.
The Nerve Monitoring Devices Market is segmented by application into cardiovascular, neurosurgery, spine surgery, ENT surgery, and other applications. The neurosurgery segment is expected to have the largest share in the nerve monitoring system market in 2017, owing to increasing number of patients suffering from neurological disorders.
Based on end users, the hospitals and surgical centers segment is expected to register fastest growth rate in the forecast period
The nerve monitoring system market is segmented into hospitals and surgical centers and ambulatory surgical centers segment. The hospitals and surgical centers is projected to be the fastest-growing end-user segment due to increasing number of complex surgical procedures, and rising number of diagnostic and surgical procedures carried out at hospitals.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=155669000
North America accounted for the largest share of the nerve monitoring system market
Geographically, the nerve monitoring system market is segmented into North America, Europe, Asia, and the Rest of the World. North America is estimated to account for the largest share of the market in 2017, which is driven by the presence of a large patient population accompanied by a well established medical reimbursement policy.
The major players of the Nerve Monitoring Devices Market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).
Analysis of the market developments between 2015 and 2017 revealed that several growth strategies such as product launches, acquisitions, mergers, and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the nerve monitoring system market. Among these business strategies, mergers and acquisitions, were the most widely adopted growth strategies by players to strengthen their product portfolios and to remain competitive in the market.
Sunday, August 16, 2020
Global Hepatitis Test Solution Industry - Emerging Trends | Proposed Tech Innovations
Major Targeted Audience for This Study:
# Blood banks
# Pathologists and pathology laboratories
# Distributors of IVD products
# Research institutes
# Hospitals and clinics
# Healthcare institutions
# Group purchasing organizations (GPOs)
# Market research and consulting firms
Hepatitis testing refers to the diagnostic procedures performed to determine what genotype of hepatitis is causing the disease and what treatment is best suited. As different hepatitis viruses cause similar symptoms, it is important to run a series of diagnostic tests to identify the virus.
The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.
The global Hepatitis Test Diagnosis Market is valued at 2.54 billion in 2017 and expected to grow at CAGR of 4.9% to USD 3.37 billion by 2023 during the forecast period.
Download PDF Brochure@
The ELISA segment is expected to hold the largest market share during the forecast period
On the basis of technology, the hepatitis test solution market is segmented into ELISA, rapid diagnostics test, PCR, INAAT, and other technologies. In 2018, the ELISA is expected to account for the largest market share, by technology. The wide acceptance of this test in clinical practices to diagnose hepatitis is the main factor driving this market.
Major Growth Drivers:
# High burden of hepatitis
# Increasing blood transfusion and donations
# Benefits of PoC instruments & kits
# Awareness initiatives
Industry Growth Restraints:
# High Cost of NAT
# Lack of mandate for NAT in developing countries
Opportunities:
# Emerging markets
North America is expected to dominate the hepatitis test solution/diagnosis market in 2018
North America is expected to account for the largest share of the global Hepatitis Test Diagnosis Market in 2018. The large share of the North America region is primarily attributed to factors such as the rising adoption of advanced technologies, developed healthcare systems in the US and Canada, and the presence of a large number of leading national clinical laboratories.
The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the hepatitis test solution market in this region is driven by the modernization of healthcare infrastructure, high burden of hepatitis infections, increased healthcare spending by a larger population base, and the rising penetration of cutting-edge clinical laboratory technologies.
Request Sample Pages@
Global Leaders in the Industry:
The key players operating in this market include Abbott Laboratories (US), Roche (Switzerland), Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), bioMérieux (France), Danaher (US), and Grifols (Spain).
Collaborations, agreements, and partnerships remain at the center of the strategic growth initiatives adopted by most of the key players in the global Hepatitis Test Diagnosis Market.
Companies such as Abbott Laboratories, Roche Diagnostics, Bio-Rad, DiaSorin, Danaher, and Grifols have been focusing on this inorganic strategy to enhance their market presence. Players also adopted product launches, product approval, and acquisition as growth strategies.
Friday, August 14, 2020
North American Healthcare IT Industry - Emerging Trends | Global Market Segmentation | Expected Revenue Growth
The study involved four major activities in estimating the size of the North America healthcare IT market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their trends at the country level. Industry experts further validated the data obtained through secondary research through primary research.
Furthermore, the market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization / adoption / penetration trends, by product and services, components, and end user). After that, market breakdown and data triangulation methods were used to estimate the size of segments and subsegments.
The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4% during the forecast period.
Market growth can be attributed to the growing need to adhere to regulatory guidelines, government initiatives for eHealth, high return on investment (ROI), and rising need to curtail the escalating healthcare costs. However, the lack of in-house IT knowledge and reluctance among end-users to adopt new methods are expected to restrain the overall market growth to a certain extent during the forecast period.
Download PDF Brochure@
Based on products and services, the healthcare providers segment accounted for the largest share of the North America healthcare IT market in 2018
Based on the products and services, the healthcare providers segment accounted for the largest share of the North American healthcare IT market in 2018. The large share of this segment is mainly attributed to the rising adoption of EHRs and other hospital information systems by healthcare providers, the inclination of the healthcare industry towards deployment of interoperable solutions, and growing regulatory requirements regarding patient information and safety.
Recent Developments:
# In 2019, Cerner Corporation launched the Next-generation cognitive health platform.
# In 2019, GE Healthcare launched Edison Datalogue and my.Cryochain software.
# In 2019, Cerner Corporation collaborated with Uniform Data System for Medical Rehabilitation to integrate their solutions that would help improve workflow for inpatient rehabilitation facilities.
# In 2019, Epic Systems partnered with Teledoc Health to integrate Teledoc Health’s virtual care platform to Epic’s App Orchard that would help the company conduct telehealth video visits.
By end-users, the healthcare providers segment accounted for the largest share of the North America healthcare IT market in 2018
Based on end-users, the North American healthcare IT market is segmented into healthcare providers and healthcare payers. The healthcare providers segment is divided further into hospitals; ambulatory care centers; home healthcare agencies, nursing homes, and assisted living facilities; diagnostic and imaging centers; and pharmacies.
Key Questions Addressed in the Report:
# Who are the top 10 players operating in the global North America healthcare IT market?
# What covers the drivers, restraints, opportunities, and challenges in the North America healthcare IT industry?
# What are the new technological advancements in the North America healthcare IT market?
# Comment on the regulatory scenario for the North America healthcare IT industry in various geographies.
# What are the growth trends in the North America healthcare IT market at the segmental and overall market levels?
North America will continue to dominate the North America healthcare IT market during the forecast period
The market, by country, is segmented into the US, Canada, and Mexico. US accounted for the largest share of the North America healthcare IT industry in 2018 due to stringent legislative and accreditation requirements regarding healthcare, high adoption rate of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of IT companies, such as EPIC Systems (U.S.), Cerner Corporation (U.S.), McKesson Corporation (U.S.), Infor, Inc. (U.S.), and Allscripts Healthcare Solutions, Inc.
Request Sample Pages@
Major Industry Leaders:
Some of the prominent players operating in the North American healthcare IT market are McKesson Corporation (US), Oracle Corporation (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Athenahealth, Inc. (US), Infor, Inc. (US), Cognizant (US), Dell Technologies (US), and CVS Health (US).
Thursday, August 13, 2020
360 Quadrants Releases Quadrant on Best Project Management Software Providers
Project management software is a computer program that enables project managers and other team members to commence, plan, implement, track, and deliver projects of all sizes and kinds. Project management software has been created to plan and store project responsibilities and events, arrange agendas and deadlines, address project problems, allocate and manage project–related expenses, set up association and support among project members, manage quality, bring together project teams, and manage human resources as well as project updates. The best project management software allows businesses to manage their projects through all the phases of the project lifecycle, right from project ideation and commencement to project implementation and conclusion.
360Quadrants has released a quadrant on best project management software to help businesses make quicker and more informed decisions. Ranking quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the project management industry. 360Quadrants conducts an in-depth SWOT analysis that helps service providers learn about new opportunities and areas where they lag behind their peers. It also helps clients choose the most appropriate vendor for their requirements.
CATEGORIZATION OF PROJECT MANAGEMENT SOFTWARE PROVIDERS
360Quadrants evaluated 45 companies in the best Project Management Software market, out of which 18 were categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies.
Asana, Smartsheet, Wrike, Airtable, Zoho Projects, Trello, Basecamp, MeisterTask, ClickUp, Teamwork, WorkFront, Aha! and Monday.com have been identified as Visionary Leaders, as they have established product portfolios and a robust market presence & business strategy.
Proofhub, and Teamleader have been identified as Innovators, as they have focused product portfolios and innovative business strategies.
Redmine has been identified as Emerging Companies, as they have niche product offerings and decent business strategies.
Flow, Freedcamp, EasyProjects and Thrive have been recognized as Dynamic Differentiators, as they are largely dependent on their competitive R&D activities.
360QUADRANTS COMPANY EVALUATION METHODOLOGY
The top companies in the Project Management Software market will be rated using the following methodology:
1. A highly experienced team of researchers and senior analysts conducts extensive research to generate a list of vendors (competitors).
2. A patent-pending algorithm is used to collect inputs from key stakeholders—industry experts, buyers, vendors, and 360Quadrants analysts—based on criteria for Product Maturity and Company Maturity.
a. Criteria under Product Maturity include breadth and depth of product/service offering, product features and functionalities, product differentiation, and their impact on customer value.
b. Criteria under Company Maturity include geographical footprint, partner ecosystem, financial stability, and client coverage or sector footprint.
3. Approximately 20+ in-depth parameters will be considered for research into the Project Management Software market. These parameters will be updated every six months to ensure the latest developments are taken into consideration.
4. A weight is assigned to each stakeholder based on information gathered pertaining to the above criteria as well as inputs from stakeholders. These inputs follow the order of priority given below:
a. Buyers
b. Industry Experts
c. 360Quadrants Analysts
d. Vendors (Competitors)
5. The inputs are analyzed, and a final rating is assigned to each vendor (competitor).
6. After the finalization of ratings, each vendor is placed in the most relevant quadrant based on their score.
ABOUT 360QUADRANTS
360Quadrants is the largest marketplace looking to disrupt USD 3.7 trillion of technology spends and is the only rating platform for vendors in the technology space. The platform provides users access to unbiased information that helps them make qualified business decisions. The platform facilitates deeper insight using direct engagement with 650+ industry experts and analysts and allows buyers to discuss their requirements with 7500 vendors. Companies get to win ideal new customers, customize their quadrants, decide key parameters, and position themselves strategically in a niche space, to be consumed by giants and startups alike. Experts get to grow their brand and increase their thought leadership. The platform targets the building of a social network that links industry experts with companies worldwide.
360Quadrants will also be launching quadrants in fields like Accounting Software, Embedded Systems, and Virtual Machine Software.
Contact:
Mr. Agney Sugla
agney@marketsandmarkets.com
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Wednesday, August 12, 2020
Global Proteomics Market Size Estimation | Emerging Trends | Future Forecasts
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
The Proteomics Research Market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.
Growth in this market is driven by increasing research activity in the area of personalized medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology sector, and rising government funding for proteomics.
Primary Research Process:
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the proteomics market.
Download PDF Brochure@
Secondary Research Process:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the proteomics market.
Critical questions the report answers:
# Where will all these developments take the industry in the long term?
# What are the upcoming trends in the proteomics market?
# Which segment provides the most opportunity for growth?
# Who are the leading vendors operating in this market?
# What are the opportunities for new market entrants?
By instrumentation technology, the spectroscopy segment is expected to account for the largest share of the market
The Proteomics Research Market, by instrumentation technology, is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The spectroscopy segment accounted for the largest market share in 2018. The ability of spectroscopy to quantify the complex structure of proteins on a large scale and its capability to integrate with other technologies for protein quantification make spectroscopy an indispensable tool in proteomics. This contributes to the large share of the segment.
Recent Developments:
# In October 2018, Waters Corporation launched its RenataDX Screening System.
# In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.
# In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer.
# In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.
# In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.
Request Sample Pages@
North America to dominate the proteomics market during the forecast period
In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.
Prominent players in the Proteomics Research Market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc.(US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA,(Germany), Waters Corporation (US), PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US).
Subscribe to:
Posts (Atom)